BACKGROUND: Because pulmonary nodules are found in up to 25% of patients undergoing computed tomography of the chest, the question of whether to perform biopsy is becoming increasingly common. Data on complications after transthoracic needle lung biopsy are limited to case series from selected institutions. OBJECTIVE: To determine population-based estimates of risks for complications after transthoracic needle biopsy of a pulmonary nodule. DESIGN: Cross-sectional analysis. SETTING: The 2006 State Ambulatory Surgery Databases and State Inpatient Databases for California, Florida, Michigan, and New York from the Healthcare Cost and Utilization Project. PATIENTS: 15 865 adults who had transthoracic needle biopsy of a pulmonary nodule. MEASUREMENTS: Percentage of biopsies complicated by hemorrhage, any pneumothorax, or pneumothorax requiring a chest tube, and adjusted odds ratios for these complications associated with various biopsy characteristics, calculated by using multivariate, population-averaged generalized estimating equations. RESULTS: Although hemorrhage was rare, complicating 1.0% (95% CI, 0.9% to 1.2%) of biopsies, 17.8% (CI, 11.8% to 23.8%) of patients with hemorrhage required a blood transfusion. In contrast, the risk for any pneumothorax was 15.0% (CI, 14.0% to 16.0%), and 6.6% (CI, 6.0% to 7.2%) of all biopsies resulted in pneumothorax requiring a chest tube. Compared with patients without complications, those who experienced hemorrhage or pneumothorax requiring a chest tube had longer lengths of stay (P < 0.001) and were more likely to develop respiratory failure requiring mechanical ventilation (P = 0.020). Patients aged 60 to 69 years (as opposed to younger or older patients), smokers, and those with chronic obstructive pulmonary disease had higher risk for complications. LIMITATIONS: Estimated risks may be inaccurate if coding of complications is incomplete. The analyzed databases contain little clinical detail (such as information on nodule characteristics or biopsy pathology) and cannot indicate whether performing the biopsy produced useful information. CONCLUSION: Whereas hemorrhage is an infrequent complication of transthoracic needle lung biopsy, pneumothorax is common and often necessitates chest tube placement. These population-based data should help patients and physicians make more informed choices about whether to perform biopsy of a pulmonary nodule. PRIMARY FUNDING SOURCE: Department of Veterans Affairs and National Cancer Institute.
BACKGROUND: Because pulmonary nodules are found in up to 25% of patients undergoing computed tomography of the chest, the question of whether to perform biopsy is becoming increasingly common. Data on complications after transthoracic needle lung biopsy are limited to case series from selected institutions. OBJECTIVE: To determine population-based estimates of risks for complications after transthoracic needle biopsy of a pulmonary nodule. DESIGN: Cross-sectional analysis. SETTING: The 2006 State Ambulatory Surgery Databases and State Inpatient Databases for California, Florida, Michigan, and New York from the Healthcare Cost and Utilization Project. PATIENTS: 15 865 adults who had transthoracic needle biopsy of a pulmonary nodule. MEASUREMENTS: Percentage of biopsies complicated by hemorrhage, any pneumothorax, or pneumothorax requiring a chest tube, and adjusted odds ratios for these complications associated with various biopsy characteristics, calculated by using multivariate, population-averaged generalized estimating equations. RESULTS: Although hemorrhage was rare, complicating 1.0% (95% CI, 0.9% to 1.2%) of biopsies, 17.8% (CI, 11.8% to 23.8%) of patients with hemorrhage required a blood transfusion. In contrast, the risk for any pneumothorax was 15.0% (CI, 14.0% to 16.0%), and 6.6% (CI, 6.0% to 7.2%) of all biopsies resulted in pneumothorax requiring a chest tube. Compared with patients without complications, those who experienced hemorrhage or pneumothorax requiring a chest tube had longer lengths of stay (P < 0.001) and were more likely to develop respiratory failure requiring mechanical ventilation (P = 0.020). Patients aged 60 to 69 years (as opposed to younger or older patients), smokers, and those with chronic obstructive pulmonary disease had higher risk for complications. LIMITATIONS: Estimated risks may be inaccurate if coding of complications is incomplete. The analyzed databases contain little clinical detail (such as information on nodule characteristics or biopsy pathology) and cannot indicate whether performing the biopsy produced useful information. CONCLUSION: Whereas hemorrhage is an infrequent complication of transthoracic needle lung biopsy, pneumothorax is common and often necessitates chest tube placement. These population-based data should help patients and physicians make more informed choices about whether to perform biopsy of a pulmonary nodule. PRIMARY FUNDING SOURCE: Department of Veterans Affairs and National Cancer Institute.
Authors: E P McCarthy; L I Iezzoni; R B Davis; R H Palmer; M Cahalane; M B Hamel; K Mukamal; R S Phillips; D T Davies Journal: Med Care Date: 2000-08 Impact factor: 2.983
Authors: Banafsheh Sadeghi; Ruth Baron; Patricia Zrelak; Garth H Utter; Jeffrey J Geppert; Daniel J Tancredi; Patrick S Romano Journal: Am J Med Qual Date: 2010 May-Jun Impact factor: 1.852
Authors: Patricia R Geraghty; Stephen T Kee; Gillian McFarlane; Mahmood K Razavi; Daniel Y Sze; Michael D Dake Journal: Radiology Date: 2003-11 Impact factor: 11.105
Authors: Maurizio Romano; Salvatore Griffo; Maria Gentile; Pier Paolo Mainenti; Oscar Tamburrini; Vittorio Iaccarino; Marco Salvatore Journal: Radiol Med Date: 2004-09 Impact factor: 3.469
Authors: Anne M Covey; Ripal Gandhi; Lynn A Brody; George Getrajdman; Howard T Thaler; Karen T Brown Journal: J Vasc Interv Radiol Date: 2004-05 Impact factor: 3.464
Authors: Hamid Pahlevaninezhad; Anthony M D Lee; Alexander Ritchie; Tawimas Shaipanich; Wei Zhang; Diana N Ionescu; Geoffrey Hohert; Calum MacAulay; Stephen Lam; Pierre Lane Journal: Biomed Opt Express Date: 2015-09-30 Impact factor: 3.732
Authors: Marvaretta Stevenson; Jared Christensen; Debra Shoemaker; Traci Foster; William T Barry; Betty C Tong; Momen Wahidi; Scott Shofer; Michael Datto; Geoffrey Ginsburg; Jeffrey Crawford; Thomas D'Amico; Neal Ready Journal: Cancer Invest Date: 2014-05-09 Impact factor: 2.176